Loading organizations...
Loading organizations...
Peptide-based technology for safe intracellular delivery of therapeutics.
Feldan Therapeutics has raised $29.0M across 2 funding rounds.
Feldan Therapeutics has raised $29.0M in total across 2 funding rounds.
Feldan Therapeutics has raised $29.0M in total across 2 funding rounds.
Feldan Therapeutics's investors include Ugur Gunaydın, FSIT2, GC Cell, GC Holdings, Guy LeBlanc, Yongjun HUH, Anges Québec Capital, Stonebridge Ventures.
Feldan Therapeutics has raised $29.0M across 2 funding rounds. Most recently, it raised $16.5M Series B in June 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 13, 2023 | $16.5M Series B | Ugur Gunaydın, FSIT2, GC Cell, GC Holdings, Guy LeBlanc | |
| Sep 18, 2018 | $12.5M Series A | Yongjun HUH | Anges Québec Capital, Stonebridge Ventures |